Home/Filings/4/0001437749-21-022139
4//SEC Filing

Balak Salesh 4

Accession 0001437749-21-022139

CIK 0001279695other

Filed

Sep 13, 8:00 PM ET

Accepted

Sep 14, 8:26 PM ET

Size

15.5 KB

Accession

0001437749-21-022139

Insider Transaction Report

Form 4
Period: 2021-08-19
Balak Salesh
Chief Financial Officier
Transactions
  • Exercise/Conversion

    Common Stock

    2021-08-19+40,000306,558 total
  • Award

    Performance Rights

    2021-08-19+500,000500,000 total
    Exp: 2025-03-24Common Stock (500,000 underlying)
  • Award

    Performance Rights

    2021-08-19+250,000250,000 total
    Exp: 2025-03-24Common Stock (250,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-08-1940,0000 total
    Exercise: $0.00Exp: 2022-01-29Common Stock (40,000 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $0.50Exp: 2024-02-27Common Stock (216,300 underlying)
    216,300
  • Stock Option (Right to Buy)

    Exercise: $0.30Exp: 2025-03-24Common Stock (500,000 underlying)
    500,000
  • Stock Option (Right to Buy)

    Exercise: $0.50Exp: 2023-04-20Common Stock (721,000 underlying)
    721,000
Footnotes (8)
  • [F1]Includes (i) 302,392 shares in the form of CDIs Mr. Balak holds directly and (ii) 4,166 restricted fully paid shares.
  • [F2]The price reported is stated in Australian dollars.
  • [F3]The options are fully vested but can only be exercised after 03/01/2021.
  • [F4]206,000 of the stock options vested and became exercisable on 10/05/2016, 412,000 of the stock options vested and became exercisable on 12/31/2016 and 103,000 of the stock options vested and became exercisable on 02/23/2017.
  • [F5]216,300 stock options vested and became exercisable on 12/31/2017.
  • [F6]13,333 stock options vested and became exercisable on 12/31/2015, 13,333 stock options vested and became exercisable on 12/31/2016, and 13,334 stock options vested and became exercisable on 12/31/2017. These options were exercised on 08/19/2021.
  • [F7]Each performance right represents a contingent right to receive one share of common stock of Universal Biosensors, Inc. ("UBI"). The performance rights vest upon, among other triggers, UBI's market capitalization having achieved a specified threshold.
  • [F8]Each performance right represents a contingent right to receive one share of common stock of UBI. The performance rights vest upon a change of control transaction with a value greater a specified threshold.

Issuer

UNIVERSAL BIOSENSORS INC

CIK 0001279695

Entity typeother

Related Parties

1
  • filerCIK 0001397500

Filing Metadata

Form type
4
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 8:26 PM ET
Size
15.5 KB